Pfiz­er's Braftovi com­bo dou­bles sur­vival time for some col­orec­tal can­cer pa­tients

Last month
R&D
Pharma

Sanofi, Re­gen­eron re­port un­der­whelm­ing COPD da­ta for IL-33 an­ti­body, shares drop

Last month
R&D

An­oth­er Bris­tol My­ers ex­ec goes to Aca­dia; David South­well takes CEO job at ARCH-backed can­cer biotech

Last month
Peer Review

Sum­mit says bis­pe­cif­ic miss­es over­all sur­vival in close­ly-watched lung can­cer study

Last month
R&D

Astel­las li­cens­es Claudin18.2 ADC from Chi­na’s Evo­point Bio­sciences

Last month
Deals
China

Supreme Court to keep mulling state PBM dis­pute as US urges jus­tices to de­cline case

Last month
Pharma
Law

The pre­ven­tive care re­brand

Last month
Health Tech

Ei­sai, Mer­ck stave off gener­ic com­pe­ti­tion to block­buster can­cer drug Lenvi­ma

Last month
Pharma
Law

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

Last month
Pharma
Manufacturing

Taysha’s piv­otal tri­al plans; Keros to stop work on PAH drug, lay off 45% of staff

Last month
News Briefing

In­tel­lia re­ports case of liv­er tox­i­c­i­ty in AT­TR gene edit­ing study

Last month
R&D

Sanofi’s vac­cine tech trans­fer in Viet­nam; Al­mac’s £1B+ rev­enue mile­stone

Last month
Manufacturing

DNA gi­ant Il­lu­mi­na spawned an ecosys­tem of com­peti­tors and cus­tomers

Last month
Startups
In Focus

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

Last month
R&D
Pharma

FDA re­jects Stealth's rare dis­ease drug, but of­fers po­ten­tial for ac­cel­er­at­ed ap­proval

Last month
FDA+
Manufacturing

Oric locks down cash for Phase 3 prostate can­cer tri­al with ear­ly da­ta in hand

Last month
R&D

Pep­Gen ditch­es Duchenne pro­grams af­ter mid-stage fail, switch­es to pre­vi­ous­ly halt­ed mus­cle wast­ing ther­a­py

Last month
R&D

Ex­clu­sive: Move­ment dis­or­der biotech Vi­ma steps on­to scene with $60M

Last month
Financing
Startups

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

Last month
Pharma
Coronavirus

The fate of Mod­er­na’s next-gen Covid shot looms large af­ter a flur­ry of pol­i­cy changes

Last month
R&D
FDA+

No­vo Nordisk ‘strong­ly’ urges against phar­ma tar­iffs as com­ments flood in

Last month
Pharma
Manufacturing

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

Last month
People
Startups

GSK, Spero re­port Phase 3 win for UTI an­tibi­ot­ic; Sper­o's stock soars

Last month
R&D

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

Last month
People
Startups
First page Previous page 13141516171819 Next page Last page
A service from the Financial Times